[Endocrine dwarfism. 2. Treatment of hypothalamo-hypophyseal dwarfism and of constitutional dwarfism with postponement of puberty].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D002648:Child; D003397:Craniopharyngioma / Q000150:complications; D004392:Dwarfism / Q000188:drug therapy*; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications; D011627:Puberty; D013974:Thyroxine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D012739:Gonadal Steroid Hormones; D006062:Gonadotropins; D013006:Growth Hormone; D013974:Thyroxine
Der endokrine Minderwuchs. 2: Die Therapie des hypothalamisch-hypophysären Minderwuchses und des konstitutionellen Minderwuchses mit Verzögerung der Pubertät